Skip to main content

memo - Magazine of European Medical Oncology OnlineFirst articles

05.12.2018 | comment

Demystification of palliative care. In regard to Masel and Kreye

Andrés Vargas

05.12.2018 | short review Open Access

Therapeutic endoscopic strategies in early esophageal cancer and dysplastic Barrett’s epithelium

Endoscopic therapy is the gold standard for curative treatment of early esophageal adenocarcinoma (EAC) including dysplastic Barrett´s epithelium (BE) and very early squamous cell carcinoma (SCC) because it is superior to surgery in regard to …

Teresa Fritz, Rainer Schöfl, Friedrich Wewalka, Alexander Ziachehabi

23.11.2018 | short review Open Access

Radiochemotherapy in esophageal cancer

Esophageal cancer is one of the ten most frequent tumors worldwide. There are two major histologies: squamous cell carcinomas, which appear more frequently in the upper part of the esophagus, and adenocarcinomas, which are predominantly found in …

Elke Mayer, Christoph Reinhold Arnold, Ute Ganswindt, Robert Jäger

19.11.2018 | short review

Diffuse large B‑cell lymphoma

Since the introduction of anti-CD20 antibodies and polychemotherapy, diffuse large B‑cell lymphoma (DLBCL) has become a treatable, and, for a high proportion of patients, curable disease. However, a sizeable proportion of patients, especially in …

David Fuchs

19.11.2018 | educational

Educational no. 4: PCR-based methods

For decades, polymerase chain reaction (PCR) has been playing a fundamental role in hematology. Not only in diagnostics, but also in follow-up and therapeutic decision-making, PCR impacts the treatment of patients with neoplastic diseases. In this …

Priv. Doz. Mag. Dr. Otto Zach

19.11.2018 | short review Open Access

A case report of pseudo-progression after pembrolizumab in metastatic gastric cancer and a review of immunotherapy in gastroesophageal tumors

In this report, we present the medical history of a 30-year-old male patient with HER2- and PD-L1-negative metastasized adenocarcinoma of the gastric cardia, who received three cycles of pembrolizumab (200  mg every 2 weeks) after the failure of …

Hossein Taghizadeh, Katharina Lampichler, Andrea Beer, Matthias Preusser, MD, PhD Aysegul Ilhan-Mutlu

11.10.2018 | case report

Kaposi sarcoma following autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia

Kaposi sarcoma (KS) is a low grade angioproliferative disorder thought to be derived from endothelial cell lineage that requires infection with human herpes virus 8 (HHV-8) for its development. This condition carries a variable clinical course …

M.D Utku Iltar, Vedat Aslan, Mesut Gocer, Fatma Aykac, İlknur Nizam, Mehmet Çelik, Faruk Gulec, Turgay Ulaş, Erdal Kurtoğlu

20.09.2018 | case report

Central nervous system-predominant Erdheim–Chester disease mimicking meningioma responding to BRAF inhibitor therapy: the importance of molecular diagnosis and targeted therapy in rare neoplastic disorders

Erdheim–Chester disease (ECD) is a rare multi-system, non-Langerhans cell histiocytic disorder (NLCHD) with only a few hundred cases reported in the literature. Its diverse clinical manifestations require a high level of diagnostic suspicion.

MBBS, DNB Amrita Chakrabarti, MBBS, MCH Anirban Deep Banerjee, MBBS, MD Ishani Mohapatra, MBBS, MD Ritesh Sachdev, MBBS, MD Bosky Jain, MBBS, MD, FRCPath Nitin Sood